Duration and level of transgene expression after gene electrotransfer to skin in mice
Authors:
- 8 April 2010
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 17 (7) , 839-845
Abstract
In development of novel vaccines, attention is drawn to DNA vaccinations. They are heat stable and can be easily produced. Gene electrotransfer is a simple and nonviral means of transferring DNA to cells and tissues and is attracting increasing interest. One very interesting perspective with gene electrotransfer is that choice of tissue can determine the duration of transgene expression. With gene electrotransfer to muscle, long-term expression, that is beyond 1 year, can be obtained, whereas gene electrotransfer to skin gives short-term expression, which is desirable in, for example, DNA vaccinations. Level and duration of transgene expression after gene electrotransfer to skin is essential and here we present data from two independent quantitative studies. Using in vivo bioimaging of a far-red fluorescent molecule, Katushka, allowing for continuous monitoring of local gene expression, compared with measurements of a systemic transgene, that is, serum erythropoietin (EPO) after gene electrotransfer with EPO to skin, we found a significant increase in transgene expression (P < 0.01) with a peak 9 days (Katushka) and 14 days (EPO) after transfection. Duration of expression could be 3-4 weeks, which is a suitable time frame for vaccinations and is applicable, for example, in gene therapy for wound healing or treatment of cancer. Gene Therapy (2010) 17, 839-845; doi:10.1038/gt.2010.35; published online 8 April 2010Keywords
This publication has 43 references indexed in Scilit:
- Skin Electroporation: Effects on Transgene Expression, DNA Persistence and Local Tissue EnvironmentPLOS ONE, 2009
- Optimization of Skin Electroporation in Mice to Increase Tolerability of DNA Vaccine Delivery to PatientsMolecular Therapy, 2009
- In Vivo Imaging of Far-red Fluorescent Proteins after DNA Electrotransfer to Muscle TissueBiological Procedures Online, 2009
- Intradermal Delivery of Plasmid VEGF165 by Electroporation Promotes Wound HealingMolecular Therapy, 2009
- Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic MelanomaJournal of Clinical Oncology, 2008
- Comparison of electrically mediated and liposome-complexed plasmid DNA delivery to the skinGenetic Vaccines and Therapy, 2008
- Optimization of cutaneous electrically mediated plasmid DNA delivery using novel electrodeGene Therapy, 2006
- Confocal fluorescence spectroscopy of subcutaneous cartilage expressing green fluorescent protein versus cutaneous collagen autofluorescenceJournal of Biomedical Optics, 2004
- High‐efficiency growth hormone releasing hormone plasmid vector administration into skeletal muscle mediated by electroporation in pigsThe FASEB Journal, 2003
- In vivo gene electroinjection and expression in rat liverFEBS Letters, 1996